CHEN SONGHU – Trademark Portfolio

Entity Type: 01

CHEN SONGHU has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 67% registration rate. The portfolio includes marks such as WAVANCE and FEMMEFORM. Filings span 3 Nice Classification classes, with the highest activity in Class 25 (Clothing) and Class 10 (Medical Apparatus). This trademark owner is based in Guangzhou.

102 NO.1 Pingxi Erxiang Liwanqv

Guangzhou 510380 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

FEMMEFORM
FEMMEFORM
Registered 2024
WAVANCE
WAVANCE
Registered 2019
ANZHEE
ANZHEE
Cancelled 2019

Trademark Classifications

CHEN SONGHU's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

28
Toys & Sporting Goods (1 filing)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

Frequently Asked Questions

How many trademarks does CHEN SONGHU have?

CHEN SONGHU has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.

What trademark classes does CHEN SONGHU file in?

CHEN SONGHU files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 10 (Medical Apparatus), Class 28 (Toys & Sporting Goods). Class 25 covers clothing, footwear, headgear.

What are CHEN SONGHU's most well-known trademarks?

CHEN SONGHU's registered trademark portfolio includes well-known marks such as WAVANCE and FEMMEFORM. These are among 2 currently registered trademarks in the portfolio.

What is CHEN SONGHU's trademark registration success rate?

CHEN SONGHU has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.